Complexation of novel thiomers and insulin to protect against in vitro enzymatic degradation – towards oral insulin delivery

References

• Carino GP, Mathiowitz E. Oral insulin delivery. Adv Drug Deliv Rev. 1999;35:249–257.
   PubMed Web of Science ®Google Scholar
• E Arbit MD, Kidron M. Oral insulin: the rationale for this approach and current developments. J Diabetes Sci Technol. 2009;3:562–567.
   PubMedGoogle Scholar
• Narayani R, Rao KP. Hypoglycemic effect of gelatin microspheres with entrapped insulin and protease inhibitor in normal and diabetic rats. Drug Deliv. 1995;2:29–38.
   Google Scholar
• Satake S, Moore MC, Igawa K, et al. Direct and indirect effects of insulin on glucose uptake and storage by the liver. Diabetes. 2002;51:1663–1671.
   PubMed Web of Science ®Google Scholar
• Pauletti G, Gangwar S, Knipp GT, et al. Structural requirements for intestinal absorption of peptide drugs. J Control Rel. 1996;41:3–17.
   Web of Science ®Google Scholar
• Fix AJ. Oral controlled release technology for peptides: status and future prospects. Pharma Res. 1996;13:1760–1764.
   Google Scholar
• Narayani R. Oral delivery of insulin-making needles needless. Trends Biomater Artif Organs 2001;15:12–16.
   Google Scholar
• Fasano A, Uzzau S. Modulation of intestinal tight junctions by zona occludens toxin permits enteral absorption of insulin and other macromolecules in an animal model. J Clin Invest. 1997;99:1158–1164.
   PubMed Web of Science ®Google Scholar
• Eaimtrakarn S, Rama Prasad YV, Ohno T, et al. Absorption-enhancing effect of labrasol on the intestinal absorption of insulin in rats. J Drug Target. 2002;10:255–260.
   PubMed Web of Science ®Google Scholar
• Kubisa P. Terminology of polymers containing ionizable or ionic groups and of polymers containing ions. IUPAC recommendations (draft 23, December 2004). Pure Appl. Chem. 2004;78:2067–2074.
   Web of Science ®Google Scholar
• Mao S, Germershaus O, Fischer D, et al. Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm Res. 2005;22:2058–2068.
   PubMed Web of Science ®Google Scholar
• Sadeghi AMM, Dorkoosh FA, Avadi MR, et al. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharma Biopharma. 2008;70:270–278.
   PubMed Web of Science ®Google Scholar
• Thompson CJ, Ding C, Qu X, et al. The effect of polymer architecture on the nano self-assemblies based on novel comb-shaped amphiphillic poly(allylamine). Colloid Polym Sci. 2008;286:1511–1526.
   Web of Science ®Google Scholar
• Yin L, Ding J, He C, et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009;30:5691–5700.
   PubMed Web of Science ®Google Scholar
• Ibie C, Thompson CJ. The oral delivery of proteins using interpolymer polyelectrolyte complexes. Therap Deliv. 2011;2:1611–1631.
   PubMedGoogle Scholar
• Ibie C, Knott RM, Thompson CJ. In vitro evaluation of the effect of polymer structure on uptake of novel polymer-insulin polyelectrolyte complexes by human epithelial cells. Int J Pharma. 2015;479:103–117.
   PubMed Web of Science ®Google Scholar
• Thompson CJ, Tetley L, Cheng WP. The influence of polymer architecture on the protective effect of novel comb-shaped amphiphillic poly(allylamine) against in vitro enzymatic degradation of insulin - Towards oral insulin delivery. Int J Pharma. 2010;260:229–237.
   Google Scholar
• Ibie C, Knott RM, Thompson CJ. Synthesis, characterisation and in-vitro evaluation of novel thiolated derivatives of Polyallylamine and Quaternised Polyallylamine. Colloid Polym Sci. 2015;293:1737–1536.
   Web of Science ®Google Scholar
• Bernkop-Schnurch A, Krauland AH, Leitner K, et al. Thiomers: potential excipients for non-invasive peptide delivery systems. Eur J Pharma Biopharma. 2004;58:253–263.
   PubMed Web of Science ®Google Scholar
• Hamman JH, Enslin GM, Kotze AF. Oral delivery of peptide drugs: barriers and developments. Biodrugs. 2005;19:165–177.
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Bouchemal K, Sharma CP, et al. Thiol-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery. Eur J Pharma Biopharma. 2010;74:209–218.
   PubMed Web of Science ®Google Scholar
• Bernkop S, A, Hornof M, Zoidl T. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharma. 2003;260:229–237.
   PubMed Web of Science ®Google Scholar
• Thompson CJ, Tetley L, Uchegbu IF, et al. The complexation between novel comb shaped amphiphillic polyallyamine and insulin – Towards oral insulin delivery. Int J Pharma. 2009;376:46–227.
   PubMedGoogle Scholar
• Simon M, Wittmar M, Bakowsky U, et al. Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)-propylcarbamate-co-(vinylacetate)-co-(vinylalcohol)-graft-poly(L-lactic acid): a novel carrier for transmucosal delivery of peptides. Bioconjugate Chem. 2004;15:841–849.
   PubMed Web of Science ®Google Scholar
• Dautzenberg H. Polyelectrolyte complex formation in highly aggregating systems. 1. Effect of salt: polyelectrolyte complex formation in the presence of NaCl. Macromolcules. 1997;30:7810–7815.
   Web of Science ®Google Scholar
• Brayden DJ, Jepson MA, Baird AW. Keynote review: Intestinal Peyer’s patch M cells and oral vaccine targeting. Drug Discov Today. 2005;10:1145–1157.
   PubMed Web of Science ®Google Scholar
• Shakweh M, Besnard M, Nicolas V, et al. Poly(lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer’s patches in mice. Eur J Pharma Biopharma. 2005;61:1–13.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31:3657–3666.
   PubMed Web of Science ®Google Scholar
• Wang W, Tetley L, Uchegbu IF. The level of hydrophobic substitution and the molecular weight of amphiphillic poly-L-lysine-based polymers strongly affects their assembly into polymeric bilayer vessicles. J Colloid Interfacial Sci. 2001;237:200–207.
   PubMed Web of Science ®Google Scholar
• Uchegbu F, Anderson S, Brownlie A. Polymeric vessicles. In: I. F. Uchegbu and A.G. Schatzlein, editors. Polymers in Drug Delivery. Boca Raton: Taylor and Francis Group;2006. p. 131–153.
   Google Scholar
• Kotz J, Tiersch B, Bogen I. Polyelectrolyte-induced vesicle formation in lamellar liquid-crystalline model systems. Colloid Polymer Sci. 2000;278:164–168.
   Web of Science ®Google Scholar
• Zhang L, Jiang H, Zhu W, et al. Improving the stability of insulin in solutions containing intestinal proteases in vitro. Ijms. 2008;9:2376–2387.
   Google Scholar
• Jintapattanakit A, Junyaprasert VB, Mao S, et al. Peroral delivery of insulin using chitosan derivatives; a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharma. 2007;342:240–249.
   PubMed Web of Science ®Google Scholar
• Lin A, Liu Y, Huang Y, et al. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int J Pharma. 2008;359:247–253.
   PubMed Web of Science ®Google Scholar
• Schilling RJ, Mitra AK. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharma Res. 1991;08:721–727.
   Google Scholar
• Jonker C, Hamman JH, Kotze AF. Intestinal paracellular permeation enhancement with quaternized chitosan: in situ and in vitro evaluation. Int J Pharma. 2002;238:205–213.
   PubMed Web of Science ®Google Scholar
• Hamman JH, Schultz CM, Kotze AF. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev Ind Pharma. 2003;29:161–172.
   Web of Science ®Google Scholar
• Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev. 2001;52:117–126.
   PubMed Web of Science ®Google Scholar